Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Sensory Index in Predicting the Success of Radiofrequency Treatment of Trigeminal Neuralgia: A Retrospective Study

NCT05748132 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.

NCT NCT05748132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05748132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Sensory Index in Predicting the Success of Radiofrequency Treatment of Trigeminal Neuralgia: A Retrospective Study
Lead sponsor
National Cancer Institute, Egypt
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2014
Completion date
March 30, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiotherapy; complications